Stem cells for bronchopulmonary dysplasia and intraventricular haemorrhage repair in preterm infants

Early Human Development

Volumn 88, Issue SUPPL.2, 2012, Pages

  Borghesi, A ^a   Maragliano, R ^a   Campanelli, R ^a   Manzoni, P ^b   Maccario, R ^a   Stronati, M ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b S ANNA HOSPITAL   (Italy)

Author keywords

BPD; Bronchopulmonary dysplasia; ECFC; Endothelial colony forming cells; Intraventricular haemorrhage; IVH; Mesenchymal stem cells; MSC; Preterm infant stem cells

Indexed keywords

ARTICLE; BONE MARROW CELL; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN PERIVENTRICULAR LEUKOMALACIA; CARCINOGENESIS; CELL POPULATION; COLONY FORMING CELL; DISEASE COURSE; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; LEUKOMALACIA; LUNG DYSPLASIA; MESENCHYMAL STEM CELL TRANSPLANTATION; NECROTIZING ENTEROCOLITIS; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PATHOGENESIS; PERINATAL ASPHYXIA; PREMATURITY; RETROLENTAL FIBROPLASIA; RISK FACTOR; SEPSIS; STEM CELL TRANSPLANTATION;

BRONCHOPULMONARY DYSPLASIA; CEREBRAL HEMORRHAGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84861464413     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/S0378-3782(12)70020-8     Document Type: Article

References (11)

1. Bancalari E, Claure N, Sosenko IR Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 2003, 8:63-71.
2. Donohue PK, Gilmore MM, Cristofalo E, Wilson RF, Weiner JZ, Lau BD, et al. Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics 2011, 127:e414-e422.
3. Balasubramaniam V, Ryan SL, Seedorf GJ, Roth EV, Heumann TR, Yoder MC, et al. Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice. Am J Physiol Lung Cell Mol Physiol 2010, 298:L315-L323.
4. van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, Bouchentouf M, et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009, 180:1131-1142.
5. Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 2009, 180:1122-1130.
6. Hirschi KK, Ingram DA, Yoder MC Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008, 28:1584-1595.
7. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatr Res 2010, 68:419-422.
8. Aguilar S, Nye E, Chan J, Loebinger M, Spencer-Dene B, Fisk N, et al. Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells 2007, 25:1586-1594.
9. Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007, 67:9142-9149.
10. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, Société Française de Greffe de Moelle et Thérapie Cellulaire, et al. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 2010, 115:1549-1553.
11. Capelli C, Gotti E, Morigi M, Rota C, Weng L, Dazzi F, et al. Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate. Cytotherapy 2011, 13:786-801.